Report on the latest innovations in oncology diagnostics market
August 22, 2015
Analysis the latest innovations in diagnostics imaging in the oncology sector, covering Magnetic Resonance Imaging (MRI), x-ray, Computed Tomography (CT), ultrasound, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and Flow Cytometry. Analyzes the latest innovations in molecular diagnostics and how they impact the diagnostics market. The report covers technology including fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), HPV testing, immunoassays & biomarkers, microarrays and comparative genomic hybridization (CGH). Analyzes the latest innovations in pharmacogenomics and covers the major applications for familial cancer, breast cancer, colon cancer and lung cancer. Also, the report provides an overview of the regulatory and intellectual property environment for genetic-based tests. Looks at the key commercial challenges for innovative diagnostics companies, including the impact of the recession, reimbursement, regulatory changes, pharmacoeconomics and the relationship between industry and academia. The report includes in-depth case studies on the potential technologies available in core areas of un-met need such as ovarian cancer and colorectal cancer.
Key Topics Covered:Innovations in oncology diagnostics Chapter 1 Setting the scene Chapter 2 Innovations in diagnostic imaging Chapter 3 Innovations in molecular diagnostics Chapter 4 Innovations in pharmacogenomics Chapter 5 Challenges in the oncology diagnostics sector Chapter 6 Competitive landscape Chapter 7 Appendix List of Figures List of Tables
Source: Business Insights